Discontinued — last reported Q2 '22
Paychex Short-Term Borrowings decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $17.60M to $0.00. Over 4 years (FY 2021 to FY 2025), Short-Term Borrowings shows an upward trend with a 25.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.40M | $7.10M | $8.90M | $8.70M | $8.70M | $10.30M | $10.10M | $10.20M | $10.20M | $13.70M | $13.60M | $18.80M | $18.70M | $18.90M | $18.20M | $17.60M | $18.60M | $18.50M | $18.20M | $0.00 |
| QoQ Change | — | -4.1% | +25.4% | -2.2% | +0.0% | +18.4% | -1.9% | +1.0% | +0.0% | +34.3% | -0.7% | +38.2% | -0.5% | +1.1% | -3.7% | -3.3% | +5.7% | -0.5% | -1.6% | -100.0% |
| YoY Change | — | — | — | — | +17.6% | +45.1% | +13.5% | +17.2% | +17.2% | +33.0% | +34.7% | +84.3% | +83.3% | +38.0% | +33.8% | -6.4% | -0.5% | -2.1% | +0.0% | -100.0% |